A new medical summarization AI agent will help healthcare organizations reduce overall prior authorization turn-around time by up to 50% UiPath will demo Vertex AI integration and showcase platform ...
UiPath Inc. (NYSE:PATH) is one of the fastest-growing agentic AI stocks to buy. UiPath’s latest results gave that growth case ...
Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...
UiPath (NYSE:PATH) currently trades at $10.39, while the average analyst price target sits at $13.80, implying upside of ...
UiPath has seen its revenue growth continually accelerate over the past year. The company has a sticky product, as evidenced by its strong net dollar retention rate. Trading at an inexpensive ...
Stocktwits on MSN
PATH, S, CRM stocks hit 52-week lows: What's driving the selloff?
UiPath and SentinelOne stocks hit record lows on Friday. ・Last week, Anthropic previewed its new AI model, Mythos, with cybersecurity applications, and launched a new product that makes it easier for ...
The latest trends in software development from the Computer Weekly Application Developer Network. UiPath used its annual developer/practitioner event this week in Las Vegas to detail the launch of the ...
UiPath recently announced a big collaboration with OpenAI to accelerate customers' return on investment by simplifying the development and deployment of AI agents. UiPath's new platform was named one ...
Software developer UiPath will cut 10% of its workforce, or about 420 jobs, as part of a broader company restructuring. UiPath shares fell 7% on Tuesday and have plunged more than 50% year-to-date. In ...
UiPath, Inc. (NYSE:PATH) is one of the cheap AI stocks to buy in 2026. On February 23, 2026, UiPath announced a suite of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results